BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 23546607)

  • 21. Preadmission use of systemic glucocorticoids and 30-day mortality following bleeding peptic ulcer: a population-based cohort study.
    Olsen M; Christensen S; Riis A; Thomsen RW
    Am J Ther; 2010; 17(1):23-9. PubMed ID: 19531935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke.
    Sundbøll J; Darvalics B; Horváth-Puhó E; Adelborg K; Laugesen K; Schmidt M; Henderson VW; Sørensen HT
    J Thromb Haemost; 2018 Nov; 16(11):2175-2183. PubMed ID: 30179297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein and risk of venous thromboembolism in the general population.
    Zacho J; Tybjaerg-Hansen A; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1672-8. PubMed ID: 20466978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of systemic glucocorticoids and the risk of colorectal cancer.
    Ostenfeld EB; Erichsen R; Thorlacius-Ussing O; Riis AH; Sørensen HT
    Aliment Pharmacol Ther; 2013 Jan; 37(1):146-52. PubMed ID: 23116185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.
    Souverein PC; Berard A; Van Staa TP; Cooper C; Egberts AC; Leufkens HG; Walker BR
    Heart; 2004 Aug; 90(8):859-65. PubMed ID: 15253953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative glucocorticoid use and risk of postoperative bleeding and infection after gastric bypass surgery for the treatment of obesity.
    Gribsholt SB; Svensson E; Thomsen RW; Richelsen B; Sørensen HT
    Surg Obes Relat Dis; 2015; 11(6):1212-7. PubMed ID: 26001556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolism after major cancer surgery: temporal trends and patterns of care.
    Trinh VQ; Karakiewicz PI; Sammon J; Sun M; Sukumar S; Gervais MK; Shariat SF; Tian Z; Kim SP; Kowalczyk KJ; Hu JC; Menon M; Trinh QD
    JAMA Surg; 2014 Jan; 149(1):43-9. PubMed ID: 24197279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute infections and venous thromboembolism.
    Schmidt M; Horvath-Puho E; Thomsen RW; Smeeth L; Sørensen HT
    J Intern Med; 2012 Jun; 271(6):608-18. PubMed ID: 22026462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone therapy and risk of venous thromboembolism among postmenopausal women in Taiwan - a 10-year nationwide population-based study.
    Lee CH; Cheng CL; Kao Yang YH; Lin LJ
    Circ J; 2015; 79(5):1107-14. PubMed ID: 25753572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study.
    Sode BF; Dahl M; Nielsen SF; Nordestgaard BG
    Am J Respir Crit Care Med; 2010 May; 181(10):1085-92. PubMed ID: 20167844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
    Bradbury BD; Lash TL; Kaye JA; Jick SS
    Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?
    Lacut K; Le Gal G; Abalain JH; Mottier D; Oger E
    Thromb Res; 2008; 122(3):314-9. PubMed ID: 18048086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study.
    Orsi FA; Lijfering WM; Geersing GJ; Rosendaal FR; Dekkers OM; le Cessie S; Cannegieter SC
    Br J Haematol; 2021 Jun; 193(6):1194-1202. PubMed ID: 33748963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.
    Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP
    Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of venous thromboembolism in users of hormone replacement therapy.
    Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
    Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study.
    Tuckuviene R; Christensen AL; Helgestad J; Johnsen SP; Kristensen SR
    J Pediatr; 2011 Oct; 159(4):663-9. PubMed ID: 21596390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.
    Holst AG; Jensen G; Prescott E
    Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant drug use and risk of venous thromboembolism.
    Jick SS; Li L
    Pharmacotherapy; 2008 Feb; 28(2):144-50. PubMed ID: 18225961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids.
    Garbe E; LeLorier J; Boivin JF; Suissa S
    Lancet; 1997 Oct; 350(9083):979-82. PubMed ID: 9329512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism after radical prostatectomy: the effect of surgical caseload.
    Schmitges J; Trinh QD; Sun M; Abdollah F; Bianchi M; Budäus L; Salomon G; Schlomm T; Perrotte P; Shariat SF; Montorsi F; Menon M; Graefen M; Karakiewicz PI
    BJU Int; 2012 Sep; 110(6):828-33. PubMed ID: 22313499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.